CERS: Cerus Corporation Stock

by  •  • Comments Off on CERS: Cerus Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 308.77
Enterprise Value ($M) 377.71
Book Value ($M) 53.44
Book Value / Share 0.29
Price / Book 5.78
NCAV ($M) 0.14
NCAV / Share 0.00
Price / NCAV 2,253.77

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio 1.55
Current Ratio 2.14

Balance Sheet (mrq) ($M)
Current Assets 144.44
Assets 197.75
Liabilities 144.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 156.37
Operating Income -26.32
Net Income -37.49
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -43.17
Cash from Investing 8.62
Cash from Financing 10.67

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Baker Bros. Advisors Lp 10.80 2.07
02-13 13G/A Vanguard Group Inc 5.45 -9.45
01-29 13G/A ARK Investment Management LLC 11.54 16.56
01-26 13G/A BlackRock Inc. 7.60 9.01

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 100,728 987,029 10.21
2024-04-30 129,538 698,912 18.53
2024-04-29 85,760 1,018,413 8.42
2024-04-26 49,168 134,101 36.66

(click for more detail)

Similar Companies
ATRC – AtriCure, Inc. CLGN – CollPlant Biotechnologies Ltd.
GUTS – Fractyl Health, Inc.


Financial data and stock pages provided by
Fintel.io